Compare PLBC & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | PLBC | THW |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Finance Companies |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 426.2M | 484.8M |
| IPO Year | 2002 | 2015 |
| Metric | PLBC | THW |
|---|---|---|
| Price | $62.34 | $12.12 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $68.00 | N/A |
| AVG Volume (30 Days) | 33.6K | ★ 111.9K |
| Earning Date | 10-27-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.79 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.11 | N/A |
| Revenue Next Year | $3.75 | N/A |
| P/E Ratio | $22.24 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $39.89 | $11.18 |
| 52 Week High | $64.00 | $14.50 |
| Indicator | PLBC | THW |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 34.69 |
| Support Level | $60.07 | $12.04 |
| Resistance Level | $63.47 | $12.87 |
| Average True Range (ATR) | 1.26 | 0.31 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 64.14 | 18.97 |
Plumas Bancorp provides banking products and services in Northeastern California and Northwestern Nevada, offering a range of deposit products for commercial and retail customers, including checking, savings, money market accounts, time deposits, retirement accounts, and sweep accounts for businesses and public entities, along with digital banking services such as mobile and internet banking, remote deposit, and electronic funds transfers, as well as other customary banking services. Its loan portfolio comprises commercial real estate, commercial and industrial, consumer, agricultural, residential real estate, and construction and land development loans, and the company generates its revenue from loans and investment securities, with additional income from service fees.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.